Table Of Content

international journal of pharmaceutics International Journal of Pharmaceutics 172 (1998) 265—266 Author index Almeida, L.M., see Gongalves, E. 172, 219 ity of 5-aminosalicylic acid against lipid peroxidation in the Attwood, D., see Suisha, F. 172, 27 presence of vitamins C and E_ 172, 219 Auger, J., see Skiba-Lahiani, M. 172, 147 Glowka, F.K., T.W. Hermann, M. Zabel, Bioavailability of Augustijns, P., see Vervoort, L. 172, 137 gliclazide from some formulation tablets 172, 71 Augustijns, P., see Vervoort, L. 172, 127 Han, C.-H., C.L. Zimmerman, T.S. Wiedmann, Spectral prop- Bak, A., see Lund, L. 172, 97 erties and ionization behavior of retinoids, II. Bile salt Bettinetti, G.P., see Maggi, L. 172, 211 solutions 172, 229 Blagden, N., R.J. Davey, R. Rowe, R. Roberts, Disappearing Han, C.-H., T.S. Wiedmann, Spectral properties and ion disso- polymorphs and the role of reaction by-products: the case of ciation behavior of retinoids I. Aqueous solutions 172, 241 sulphathiazole 172, 169 Han, R.-Y., see Sung, K.C. 172, 17 Boerefijn, R., Z. Ning, M. Ghadiri, Disintegration of weak Hermann, T.W., see Glowka, F.K. 172, 71 lactose agglomerates for inhalation applications 172, 199 Herrera, M.C., see Palomero, M.F. 172, 79 Hino, T., see Kawashima, Y. 172, 179 Chow, A.H.L., 8.S.S. Ho, H.H.Y. Tong, H.H.M. Ma, Parame- Ho, S.S.S., see Chow, A.H.L. 172, 113 ters affecting in-liquid drying microencapsulation and release Hovgaard, L., see Lund, L. 172, 97 rate of cefaclor 172, 113 Hsu, L.-R., see Sung, K.C. 172, 17 Christrup, L.L., see Lund, L. 172, 97 Huang, Y.-Y., T.-W. Chung, C.-I. Wu, Effect of saturated/un- Chung, T.-W., see Huang, Y.-Y. 172, 161 saturated phosphatidylcholine ratio on the stability of lipo- Conte, U., see Maggi, L. 172, 211 some-encapsulated hemoglobin 172, 161 Cortesi, R., see Esposito, E. 172, 255 Hu, O.Y.P., see Sung, K.C. 172, 17 Courtot, A.-M., see Skiba-Lahiani, M. 172, 147 Isowa, K., see Morishita, M. 172, 189 Davey, R.J., see Blagden, N. 172, 169 Itoh, T., M. Tanno, Y.-H. Li, H. Yamada, Transport of Delattre, J., see Skiba-Lahiani, M. 172, 147 phenethicillin into rat intestinal brush border membrane Dicks, H., see Feeley, J.C. 172, 89 vesicles: role of the monocarboxylic acid transport sys- Dinis, T.C.P., see Goncalves, E. 172, 219 tem 172, 103 El-Mir, M.Y., see Palomero, M.F. 172, 79 Kawasaki, N., see Suisha, F. 172, 27 Esposito, E., C. Zanella, R. Cortesi, E. Menegatti, C. Nastruzzi, Kawashima, Y., T. Serigano, T. Hino, H. Yamamoto, H. Influence ofl iposomal formulation parameters on the in vitro Takeuchi, Effect of surface morphology of carrier lactose on absorption of methyl nicotinate 172, 255 dry powder inhalation property of pranlukast hydrate 172, 179 Fattal, E., see Skiba-Lahiani, M. 172, 147 Kinget, R., see Vervoort, L. 172, 137 Feeley, J.C., P. York, B.S. Sumby, H. Dicks, Determination of Kinget, R., see Vervoort, L. 172, 127 surface properties and flow characteristics of salbutamol sulphate, before and after micronisation 172, 89 Li, Y.-H., see Itoh, T. 172, 103 Friis, G.J., see Lund, L. 172, 97 Lund, L., A. Bak, G.J. Friis, L. Hovgaard, L.L. Christrup, The enzymatic degradation and transport of leucine—enkephalin Ghadiri, M., see Boerefijn, R. 172, 199 and 4-imidazolidinone enkephalin prodrugs at the blood- Gongalves, E., L.M. Almeida, T.C.P. Dinis, Antioxidant activ- brain barrier 172, 97 PIT $0378-5173(98)00275-0 266 Author index Macias, R.I.R., see Palomero, M.F. 172, 79 sustained release vehicles for the intraperitoneal administra- Maggi, L., U. Conte, G.P. Bettinetti, Technological properties tion of mitomycin C_ 172, 27 of crystalline and amorphous «-cyclodextrin hydrates 172, Sumby, B.S., see Feeley, J.C. 172, 89 211 Sung, K.C., R.-Y. Han, O.Y.P. Hu, L.-R. Hsu, Controlled Ma, H.H.M., see Chow, A.H.L. 172, 113 release of nalbuphine prodrugs from biodegradable poly- Marin, J.J.G., see Palomero, M.F. 172, 79 meric matrices: influence of prodrug hydrophilicity and poly- Matsuzawa, A., see Morishita, M. 172, 189 mer composition 172, 17 Menegatti, E., see Esposito, E. 172, 255 Miyazaki, S., see Suisha, F. 172, 27 Takayama, K., see Morishita, M. 172, 189 Morishita, M., A. Matsuzawa, K. Takayama, K. Isowa, T. Takeuchi, H., see Kawashima, Y. 172, 179 Nagai, Improving insulin enteral absorption using water-in- Tanno, M., see Itoh, T. 172, 103 oil-in-water emulsion 172, 189 Tong, H.H.Y., see Chow, A.H.L. 172, 113 Nagai, T., see Morishita, M. 172, 189 Uchegbu, I.F., S.P. Vyas, Non-ionic surfactant based vesicles Nastruzzi, C., see Esposito, E. 172, 255 (niosomes) in drug delivery 172, 33 Nikas, G., see Skiba-Lahiani, M. 172, 147 Ning, Z., see Boerefijn, R. 172, 199 Van den Mooter, G., see Vervoort, L. 172, 137 Van den Mooter, G., see Vervoort, L. 172, 127 Palomero, M.F., M.C. Herrera, R.I.R. Macias, M.Y. El-Mir, Vervoort, L., G. Van den Mooter, P. Augustijns, R. Kinget, G.R. Villanueva, J.J.G. Marin, Transient enterohepatic cir- Inulin hydrogels. I. Dynamic and equilibrium swelling prop- culation and enhanced biliary versus urinary excretion of the erties 172, 127 cytostatic drug bischolylglycinate-chloroplatinum(II) Vervoort, L., P. Rombaut, G. Van den Mooter, P. Augustijns, (Bamet-H2) 172, 79 R. Kinget, Inulin hydrogels. II. In vitro degradation Panchagnula, R., Pharmaceutical aspects of paclitaxel 172, | study 172, 137 Villanueva, G.R., see Palomero, M.F. 172, 79 Roberts, R., see Blagden, N. 172, 169 Vyas, S.P., see Uchegbu, I.F. 172, 33 Rombaut, P., see Vervoort, L. 172, 137 Rowe, R., see Blagden, N. 172, 169 Wiedmann, T.S., see Han, C.-H. 172, 2 Wiedmann, T.S., see Han, C.-H. 172, 22 Sasaki, M., see Suisha, F. 172, 27 Wu, C.-I., see Huang, Y.-Y. 172, 161 Serigano, T., see Kawashima, Y. 172, 179 Shirakawa, M., see Suisha, F. 172, 27 Yamada, H., see Itoh, T. 172, 103 Skiba-Lahiani, M., M. Skiba, G. Nikas, J. Auger, E. Fattal, J. Yamamoto, H., see Kawashima, Y. 172, 179 Delattre, A.-M. Courtot, Interaction between PC12 lipo- Yamatoya, K., see Suisha, F. 172, 27 somes encapsulating ATP and human spermatozoa 172, York, P., see Feeley, J.C. 172, 89 147 Skiba, M., see Skiba-Lahiani, M. 172, 147 Zabel, M., see Glowka, F.K. 172, 71 Suisha, F., N. Kawasaki, S. Miyazaki, M. Shirakawa, K. Zanella, C., see Esposito, E. 172, 255 Yamatoya, M. Sasaki, D. Attwood, Xyloglucan gels as Zimmerman, C.L., see Han, C.-H. 172, 229